NEU 0.98% $19.50 neuren pharmaceuticals limited

Trying to get a handle on the potential value of the upcoming...

  1. 872 Posts.
    lightbulb Created with Sketch. 72
    Trying to get a handle on the potential value of the upcoming phase 2 NNZ 2591 results...

    If NEU get the $250 mil USD millstone this year ($77 million AUD) and another $65 million in royalty, the cash balance would be about $350 million at the end of the year.

    If the Daybue royalty levels off at $80 million PA leaving a NPAT of say $50 million, and assuming a PE of 16 ($800 million), and the cash, would give a market cap of $1.1 billion....

    Current market cap is $2.4 billion, implying the market is valuing the other trials at $1.3 billion dollars.

    If half of this $1.3 billion is attributed to the upcoming phase 2 results, then could see a $650 million or 25% come off the market cap/share price if results disappoint...

    It will be interesting to see how the market reacts if the results are OK...so neither an obvious failure or success, which I think is most likely.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.50
Change
0.190(0.98%)
Mkt cap ! $2.490B
Open High Low Value Volume
$19.39 $19.98 $19.38 $7.285M 370.6K

Buyers (Bids)

No. Vol. Price($)
11 7318 $19.50
 

Sellers (Offers)

Price($) Vol. No.
$19.52 593 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$19.55
  Change
0.190 ( 0.83 %)
Open High Low Volume
$19.41 $19.97 $19.39 83274
Last updated 15.59pm 14/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.